[go: up one dir, main page]

ATE189394T1 - Methode zur behandlung von viralen infektionen - Google Patents

Methode zur behandlung von viralen infektionen

Info

Publication number
ATE189394T1
ATE189394T1 AT92925395T AT92925395T ATE189394T1 AT E189394 T1 ATE189394 T1 AT E189394T1 AT 92925395 T AT92925395 T AT 92925395T AT 92925395 T AT92925395 T AT 92925395T AT E189394 T1 ATE189394 T1 AT E189394T1
Authority
AT
Austria
Prior art keywords
crp
modified
virus
viral infections
treating viral
Prior art date
Application number
AT92925395T
Other languages
English (en)
Inventor
Lawrence A Potempa
Original Assignee
Immtech Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immtech Int Inc filed Critical Immtech Int Inc
Application granted granted Critical
Publication of ATE189394T1 publication Critical patent/ATE189394T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4737—C-reactive protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92925395T 1991-11-27 1992-11-23 Methode zur behandlung von viralen infektionen ATE189394T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79944891A 1991-11-27 1991-11-27
PCT/US1992/010126 WO1993010799A1 (en) 1991-11-27 1992-11-23 Method of treating viral infections

Publications (1)

Publication Number Publication Date
ATE189394T1 true ATE189394T1 (de) 2000-02-15

Family

ID=25175937

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92925395T ATE189394T1 (de) 1991-11-27 1992-11-23 Methode zur behandlung von viralen infektionen

Country Status (8)

Country Link
US (1) US5585349A (de)
EP (1) EP0616535B1 (de)
JP (1) JP3457309B2 (de)
AT (1) ATE189394T1 (de)
AU (1) AU662787B2 (de)
CA (1) CA2123786C (de)
DE (1) DE69230643T2 (de)
WO (1) WO1993010799A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6239099B1 (en) 1991-11-27 2001-05-29 Immtech International, Inc. Methods of treating viral infections
US5874238A (en) * 1993-02-26 1999-02-23 Immtech International Inc. Mutant protein and methods and materials for making and using it
US6703219B1 (en) 1993-02-26 2004-03-09 Immtech International Inc. Mutant protein and methods and materials for making and using it
US5547931A (en) * 1994-02-23 1996-08-20 Immtech International Inc. Methods of stimulatory thrombocytopoiesis using modified C-reactive protein
DE69716741T2 (de) * 1996-01-25 2003-06-12 Profylakse Aps, Odense Pharmazeutische zusammensetzung, enthaltend serum-amyloid p-komponenten, zur prophylaxe und therapie von viralen infektionen sowie kit zur detektionvon komplexen zwischen solchen zusammensetzungen und viralen komponenten
US5850333A (en) * 1997-03-19 1998-12-15 Ingersoll-Rand Company Enclosure for machine control panel
US6331403B1 (en) * 1998-08-19 2001-12-18 Lawrence A. Potempa Use of mCRP to slow cell growth and to promote maturation of cells
US6190670B1 (en) * 1999-04-12 2001-02-20 Immtech International Inc. Use of mCRP to enhance immune responses
WO2005058359A2 (en) * 2003-12-15 2005-06-30 Theralogic Gmbh & Co. Kg Method for neutralizing effects of crp for increasing immune reactions to hiv
US9150631B2 (en) 2010-01-19 2015-10-06 President And Fellows Of Harvard College Engineered opsonin for pathogen detection and treatment
JP2014523914A (ja) 2011-07-18 2014-09-18 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 操作された微生物標的化分子およびその使用
EP2976642A4 (de) 2013-03-15 2016-09-21 Harvard College Verfahren und zusammensetzungen zur verbesserung der erkennung und/oder aufnahme einer zieleinheit
AU2014268603B2 (en) 2013-05-21 2018-03-22 President And Fellows Of Harvard College Engineered heme-binding compositions and uses thereof
US10513546B2 (en) 2013-12-18 2019-12-24 President And Fellows Of Harvard College CRP capture/detection of gram positive bacteria
US10435457B2 (en) 2015-08-06 2019-10-08 President And Fellows Of Harvard College Microbe-binding molecules and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0411017B1 (de) * 1988-04-04 1996-03-06 POTEMPA, Lawrence A. Bindung von immunkomplexen durch modifizierte formen von c-reaktiven proteinen
DD294568A5 (de) * 1989-07-14 1991-10-02 Humboldt-Universitaet,Direkt. F. Forsch.,De Verfahren zur bestimmung von c-reaktivem protein
NL9100434A (nl) * 1991-03-11 1992-10-01 Rijksuniversiteit Farmaceutische preparaten voor de bestrijding van virale infecties en immuundeficientieziekten, de bereiding en toepassing daarvan.
AU2006892A (en) * 1991-05-16 1992-12-30 Associates Of Cape Cod, Inc. Endotoxin binding and neutralizing protein and uses thereof
US5283238A (en) * 1992-04-24 1994-02-01 Immtech International, Inc. Methods of treating cancer using modified C-reactive protein

Also Published As

Publication number Publication date
DE69230643D1 (de) 2000-03-09
EP0616535A1 (de) 1994-09-28
DE69230643T2 (de) 2000-06-21
AU662787B2 (en) 1995-09-14
CA2123786A1 (en) 1993-06-10
US5585349A (en) 1996-12-17
AU3146893A (en) 1993-06-28
EP0616535A4 (de) 1995-07-12
JPH07501544A (ja) 1995-02-16
CA2123786C (en) 2000-08-01
EP0616535B1 (de) 2000-02-02
WO1993010799A1 (en) 1993-06-10
JP3457309B2 (ja) 2003-10-14

Similar Documents

Publication Publication Date Title
DE69230643D1 (de) Methode zur behandlung von viralen infektionen
Gellis et al. Chemical, clinical, and immunological studies on the products of human plasma fractionation. XXXVI. Inactivation of the virus of homologous serum hepatitis in solutions of normal human serum albumin by means of heat
NO874364D0 (no) Antivirus-immunoterapeutisk middel og fremstilling derav.
ATE138575T1 (de) Verfahren zur inaktivierung von viren in mit viren verunreinigten pharmazeutischen zusammensetzungen
ATE231549T1 (de) Verfahren zur konservierung von infektiösen rekombinierenden viren, virale wässrige suspension und ihre medizinische verwendung
ATE108068T1 (de) Antikörper-heterokonjugate zur töting von hiv- infizierten zellen.
DE69535758D1 (de) Lipid-analoge zur behandlung von viralen infektionen
HK45193A (en) Ozone decontamination of blood and blood products
DK184186A (da) Terapeutisk praeparat til behandling af virussygdomme
ATE475423T1 (de) Immunostimulierende polynukleotide sequenzen zur verwendung bei der verhinderung und behandlung von viralen erkrankungen
EA199700215A1 (ru) Защита от вирусных инфекций путем колонизации слизистых оболочек генетически модифицированными бактериями
ATE116637T1 (de) Sulfonische stilbenderivate zur behandlung von viruserkrankungen.
ATE362379T1 (de) Induktion rev- und tat-spezifischer zytotoxischer t-zellen zur prävention und behandlung einer infektion durch humanen immundefizienz-virus (hiv)
ATE165345T1 (de) Sulfonsaeurederivate zur behandlung von viruserkrankungen
ATE89735T1 (de) Pharmazeutische zubereitung zur behandlung von viruskrankheiten mit leber-extrakt.
ATE136468T1 (de) Impfstoff zur behandlung von hsv
DK577181A (da) Polypeptidfraktioner fra muslinger
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
ATE115863T1 (de) Verwendung eines immunglobulinhaltigen präparates zur prophylaxe und therapie von aids beim menschen.
DK0653939T3 (da) Anvendelse af en Hymenoptera-gift til fremstilling af et medikament til behandling af DNA-virusinfektioner
ATE155795T1 (de) Verwendung von leukoregulin zur behandlung von mit einem envelope-virus infizierten tier
DK135588D0 (da) Inaktivering af hiv i proteinholdige oploesninger ved hjaelp af phenoler
ATE255417T1 (de) Verwendung von bradykinin-antagonisten zur behandlung von viruserkrankungen
EA199700353A1 (ru) Композиция и способ для определения приобретенного синдрома иммунодефицита, способ приготовления названной композиции
DE69210737D1 (de) Verwendung von L-2-Oxothiazolidine-4-Carboxylate zur Herstellung eines Arzneimittels zur Behandlung von latenten HIV-Infektionen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties